// App-Quantinova.ai

e23061 : Soluble human histocompatibility antigens (HLA) as potential biomarkers for early detection of non-small lung carcinoma (NSCLC).

Researchers

Presenter

  • Smriti Kanangat

Principal Investigators

  • Melissa R Pergande

  • Cristina L. Fhied

  • Gabriela C Lobato

  • Imad Tarhoni

  • Gary Chmielewski

  • Michael J. Liptay

  • Christopher W. Seder

  • Jeffrey Allen Borgia

Medical Centers

  • Rush University Medical Center, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Solid malignancies

  • Non Small Cell Lung cancer

Biomarkers

  • Major Histocompatibility Complex, Class II, DQ Alpha 1

  • Major histocompatibility complex, class II, DR beta 1

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved